Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
General Pulmonary
Does rituximab have a potential role in the management of immune checkpoint inhibitor induced pneumonitis?
Related Questions
Do you routinely obtain a CXR or CT after identifying an etiology for dyspnea on POCUS?
Do you prescribe empiric antibiotics to patients with CAP who test positive for a respiratory virus?
What’s your approach to an asymptomatic, hemodynamically stable patient with moderate spontaneous pneumomediastinum without pneumothorax and normal esophagogram?
What are your vaccine recommendations while patients are on biologics?
How do you mitigate risk when performing bronchoscopy in hypoxic patients requiring high levels of supplemental oxygen?
What is your next step in treatment for tobacco use disorder for a patient who continues to smoke after 12 weeks of therapy with varenicline?
When you interpret a PFT officially, do you include a comparison to an older PFT on your report?
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
If PFTs are done on different machines or different places, are the comparisons valid?
What are your top takeaways from CHEST 2025?
